ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 88 filers reported holding ENZO BIOCHEM INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $241,000 | -5.1% | 23,002 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $254,000 | -72.4% | 23,002 | -79.1% | 0.00% | -75.0% |
| Q1 2017 | $921,000 | +51.2% | 110,019 | +25.5% | 0.00% | +33.3% |
| Q4 2016 | $609,000 | +372.1% | 87,688 | +245.0% | 0.00% | +200.0% |
| Q3 2016 | $129,000 | -15.1% | 25,417 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $152,000 | +97.4% | 25,417 | -3.1% | 0.00% | – |
| Q1 2015 | $77,000 | -33.6% | 26,236 | 0.0% | 0.00% | – |
| Q4 2014 | $116,000 | -14.1% | 26,236 | 0.0% | 0.00% | -100.0% |
| Q3 2014 | $135,000 | 0.0% | 26,236 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $135,000 | +13400.0% | 25,801 | +5060.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |